Department of Commerce of Guangdong Province Held the Press Conference of Guangdong Foreign Investment Policy Interpretation and Pharmaceutical Industry Research Report

　　To implement the new arrangements on the promotion of the new pattern of all-round opening up made by 19th National Congress of the Communist Party of China, further expand opening-up, advance the development of foreign-funded pharmaceutical industry in Guangdong Province, and undertake the interpretation and publicity of Policies and Measures of People's Government of Guangdong Province on Further Expanding Opening-up and Actively Attracting Foreign Direct Investment (hereinafter referred to as Ten Policies and Measures for Foreign Investment), on the morning of January 19^th, Department of Commerce of Guangdong Province held the Press Conference of Guangdong Foreign Investment Policy Interpretation and Pharmaceutical Industry Research Report. More than 30 foreign-invested pharmaceutical enterprises attended the meeting, such as Pfizer, Sanofi, Johnson &Johnson, Bayer, Eli Lilly and Company, Roche Group, Merck, Novartis, Novo Nordisk, Astrazeneca, Glaxosmithkline, Takeda, Baxter and etc.  

　　During the meeting, Mr. Wu Jun, Director of Port Administration Office of the People’s Government of Guangdong Province and Deputy Director-General of Department of Commerce of Guangdong Province, made a speech and introduced the background and significance of The Ten Policies and Measures for Foreign Investment, Foreign Investment Administration Division of the Department interpreted the content of The Ten Policies and Measures for Foreign Investment, China Association of Enterprises with Foreign Investment R&D-based Pharmaceutical Association Committee (RDPAC) released the industry research report Improve the Availability of Innovative Drugs to Advance Health in China. Officials from Economic and Information Commission of Guangdong Province, Human Resources and Social Security Department of Guangdong Province, Health and Family Planning Commission of Guangdong Province, Guangdong Food and Drug Administration, Guangdong Intellectual Property Office interpreted the contents related to their Departments and had active communication with the enterprises. Representatives of Sanofi, Lundbeck, Baxter, Merck etc. made speeches and asked questions and received active response from relevant officials .